FGF2 and cancer: Later, pro-tumorigenic activity will prevail by secreting survival factors (bFGF, HGF, IGF1), pro-angiogenic agents (VEGF, TGFB), immunosuppressive cytokines (IDO, TGFB, IL8, IL10), and transform to cancer-associated fibroblast (CAF) [7].